CHINA PHARMA HOLDINGS, INC. Accounts Receivable
CHINA PHARMA HOLDINGS, INC. (CPHI) had Accounts Receivable of $181.62 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current › Accounts and Financing Receivable, after Allowance for Credit Loss, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2026-08-14
- 2026-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $181.62K.
- 2026-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $196.26K.
- 2025-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $241.41K.
- 2025-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $224.64K.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current | Accounts Receivable, after Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2026-06-30 | $181.62K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $196.26K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $241.41K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $224.64K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $268.79K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $328.90K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $232.14K 10-K · filed 2026-04-01 | |
| 2024-09-30 | $333.37K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $254.85K 10-Q · filed 2024-08-14 | |
| 2023-12-31 | $504.45K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $368.23K 10-Q · filed 2023-11-13 | |
| 2022-12-31 | $421.53K 10-K · filed 2024-04-01 | |
| 2017-12-31 | $2.29M 10-K · filed 2018-04-02 | |
| 2016-12-31 | $4.00M 10-K · filed 2018-04-02 | |
| 2015-12-31 | $5.88M 10-K · filed 2016-03-30 | |
| 2015-09-30 | $11.78M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $17.18M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $18.81M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $13.85M 10-K · filed 2016-03-30 | $24.85M 10-K · filed 2015-03-30 |
| 2014-09-30 | $30.64M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $35.90M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $42.34M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $45.15M 10-K · filed 2015-03-30 | |
| 2013-06-30 | $55.36M 10-Q · filed 2013-08-14 | |
| 2012-12-31 | $66.18M 10-K · filed 2014-03-20 | |
| 2012-09-30 | $69.82M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $71.36M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $73.55M 10-Q · filed 2012-05-14 | |
| 2011-12-31 | $69.70M 10-Q · filed 2012-11-14 | |
| 2011-09-30 | $68.72M 10-Q/A · filed 2012-03-06 | |
| 2011-06-30 | $66.14M 10-Q/A · filed 2011-09-06 | |
| 2010-12-31 | $61.95M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |